Bio-Techne (TECH) EBT Margin (2009 - 2026)

Bio-Techne's EBT Margin history runs 18 years deep, the most recent figure standing at 22.87% for Q1 2026.

• On a quarterly basis, EBT Margin rose 1077.0% year-over-year to 22.87% in Q1 2026; TTM through Mar 2026 was 4.98%, a 760.0% decrease from a year earlier, with the FY2025 full-year figure at 0.96%, down 1413.0% from the prior year.
• EBT Margin improved to 22.87% in Q1 2026 per TECH's latest filing, from 17.16% in the prior quarter.
• Across five years, EBT Margin topped out at 5185.8% in Q3 2022 and bottomed at 34.6% in Q2 2025.
• The 5-year median for EBT Margin is 17.9% (2023), against an average of 320.05%.
• Across the five-year window, EBT Margin surged 515965 bps in 2022 and sank 516790 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 24.46% in 2022, then tumbled by 50 bps to 12.25% in 2023, then grew by 18 bps to 14.43% in 2024, then advanced by 19 bps to 17.16% in 2025, then jumped by 33 bps to 22.87% in 2026.
• Per Business Quant, the three latest TECH EBT Margin figures stand at 22.87% (Q1 2026), 17.16% (Q4 2025), and 16.75% (Q3 2025).